35 Ken Fisher Hologic Trades
Ken Fisher's position in Hologic is currently worth $675 Thousand. That's 0.00% of their equity portfolio (725th largest holding). The first Hologic trade was made in Q1 2013. Since then Ken Fisher bought shares thirteen more times and sold shares on 21 occasions. The stake costed the investor $393 Thousand, netting the investor a gain of 72% so far.
News about Hologic, Inc. and Ken Fisher
Global RSV Diagnostic Market Expected To Reach $ 1,474.31 Million Growth By 2027||F. Hoffman La. Roche Ltd, Danaher, Thermo Fisher Scientific Inc., Luminex Corporation, BioCartis, Hologic, Inc
The RSV diagnostic report published by Data Bridge Market research is the representation of data and analysis of the market. It gives detailed analysis of th...
TB Diagnostic Market Growth, Trends, COVID-19 Impact, and Forecasts (2021 2027)| Abbott Laboratories, Abbott, Becton Dickinson and Company, bioMrieux, Cepheid, F. Hoffman La Roche, Hain Lifescience, Hologic Corporation, Thermo Fisher Scientific
The latest TB Diagnostic market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable pl...
Buys Dominate Robert Olstein''s 2nd-Quarter Portfolio
Guru invests in manufacturing, medical devices and more Check out Mario Gabelli Stock Picks » Download GuruFolio Report of Mario Gabelli (Updated on 08/10/20...
PCR For Respiratory Infection Diagnostic Market is expected to reach US$ 8279.32 Mn With CAGR of 10.4% from 2021 to 2028 | Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Abbott; F. Hoffmann-La Roche Ltd; Hologic, Inc.; Seegene Inc.; AusDiagnost
According to our new research study on PCR for respiratory infection diagnostics market Forecast to 2028 COVID-19 Impact and Global Analysis by Type, Produ...